RASH
MCID: EXN002
MIFTS: 57

Exanthem (RASH)

Categories: Infectious diseases, Skin diseases

Aliases & Classifications for Exanthem

MalaCards integrated aliases for Exanthem:

Name: Exanthem 12 15 17
Exanthema 12 43
Rash 12 15
Rashes 42

Classifications:



External Ids:

Disease Ontology 12 DOID:0050486
ICD9CM 34 782.1
MeSH 43 D005076
NCIt 49 C39594
SNOMED-CT 67 271807003
ICD10 32 R21
UMLS 71 C0015230

Summaries for Exanthem

MedlinePlus : 42 A rash is an area of irritated or swollen skin. Many rashes are itchy, red, painful, and irritated. Some rashes can also lead to blisters or patches of raw skin. Rashes are a symptom of many different medical problems. Other causes include irritating substances and allergies. Certain genes can make people more likely to get rashes. Contact dermatitis is a common type of rash. It causes redness, itching, and sometimes small bumps. You get the rash where you have touched an irritant, such as a chemical, or something you are allergic to, like poison ivy. Some rashes develop right away. Others form over several days. Although most rashes clear up fairly quickly, others are long-lasting and need long-term treatment. Because rashes can be caused by many different things, it's important to figure out what kind you have before you treat it. If it is a bad rash, if it does not go away, or if you have other symptoms, you should see your health care provider. Treatments may include moisturizers, lotions, baths, cortisone creams that relieve swelling, and antihistamines, which relieve itching.

MalaCards based summary : Exanthem, also known as exanthema, is related to viral exanthem and measles. An important gene associated with Exanthem is CCR6 (C-C Motif Chemokine Receptor 6), and among its related pathways/superpathways are ERK Signaling and PEDF Induced Signaling. The drugs Vancomycin and Enalapril have been mentioned in the context of this disorder. Affiliated tissues include skin, lung and breast, and related phenotypes are cardiovascular system and homeostasis/metabolism

Disease Ontology : 12 A skin disease that is characterized by a rash that results from a variety of causes including bacteria, viruses, toxins, drugs and autoimmune disorders.

Wikipedia : 74 An exanthem is a widespread rash occurring on the outside of the body and usually occurring in children.... more...

Related Diseases for Exanthem

Diseases in the Exanthem family:

Bacterial Exanthem Viral Exanthem

Diseases related to Exanthem via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1027)
# Related Disease Score Top Affiliating Genes
1 viral exanthem 34.8 CRP CD8A CD40LG CD4
2 measles 31.6 TNF IL6 IL2 CD40LG
3 covid-19 31.6 IL6 GPT CRP CD8A
4 purpura 31.4 TNF IL6 CRP CD40LG
5 urticaria 31.4 TNF IL6 CRP CD40LG
6 drug reaction with eosinophilia and systemic symptoms 31.4 TNF CRP
7 rubella 31.3 TNFRSF1B TNF IL6 IL2 GPT CD40LG
8 mouth disease 31.3 IL6 ICOSLG H2AC18 CRP CCR6
9 contact dermatitis 31.3 TNF IL6 IL2 CD4
10 meningitis 31.3 TNF IL6 IL2 CRP CD40LG ALB
11 dermatitis 31.3 TNF IL6 IL2 CTLA4 CCR6
12 erythema multiforme 31.3 TNF IL6 IL2
13 aseptic meningitis 31.3 TNF IL1RN CRP CD40LG
14 secondary syphilis 31.2 CD8A CD40LG CD4
15 mumps 31.2 TNFRSF1B TNF IL6 IL2 CD40LG
16 allergic hypersensitivity disease 31.2 TNF IL2 ICOSLG H2AC18 CYP3A4 CD4
17 chickenpox 31.2 TNFRSF1B TNF IL6 IL2 CTLA4 CRP
18 scarlet fever 31.2 TNF CRP CD40LG ALB
19 african tick-bite fever 31.2 TNF IL6 GPT CD40LG
20 epidemic typhus 31.1 GPT CRP CD8A CD40LG CD4
21 vasculitis 31.1 TNFRSF1B TNF IL6 CTLA4 CRP CD40LG
22 stomatitis 31.0 TNF IL6 IL2 IL1RN CD40LG CD4
23 poliomyelitis 31.0 TNF CD8A CD40LG CD4
24 spotted fever 31.0 TNF CTLA4 CD40LG
25 lymphadenitis 31.0 TNF ICOSLG CRP CD4 CCR6
26 dengue disease 31.0 TNF ICOSLG H2AC18 CD8A CD40LG
27 kawasaki disease 31.0 TNF IL6 IL2 GPT CRP CD40LG
28 guillain-barre syndrome 30.9 TNFRSF1B TNF CD40LG CCR6 ALB
29 cat-scratch disease 30.9 CRP CD40LG CD4
30 smallpox 30.9 TNF IL2 IL1RN
31 coccidioidomycosis 30.9 TNF CD40LG CD4 CCR6
32 monkeypox 30.9 CD8A CD40LG CD4
33 drug allergy 30.9 GPT CYP3A4 CRP CD40LG CD4 ALB
34 allergic contact dermatitis 30.9 TNF IL6 CD4
35 lassa fever 30.8 CD8A CD40LG CD4
36 erysipelas 30.8 TNF IL6 IL2 IL1RN CRP CD40LG
37 thrombocytopenic purpura, autoimmune 30.8 ICOSLG CD40LG CD4 CCR6
38 parotitis 30.8 CRP CD40LG CD4 ALB
39 streptococcal toxic-shock syndrome 30.8 TNF IL6 IL2
40 pleural empyema 30.8 CRP CD40LG CD4 ALB
41 vaccinia 30.8 TNF IL6 IL2 CTLA4 CD274
42 folliculitis 30.8 TNF CD4 CCR6
43 acrodermatitis 30.8 TNFRSF1B CD40LG ALB
44 yellow fever 30.8 IL6 IL1RN CRP CCR6
45 ileus 30.8 TNF IL6 CRP
46 interstitial nephritis 30.8 ICOSLG CRP CD40LG CCR6 ALB
47 adult-onset still's disease 30.8 TNF IL6 IL1RN CRP
48 dengue shock syndrome 30.8 TNF IL6 IL1RN CD40LG
49 lyme disease 30.8 TNF IL6 CRP CD40LG
50 uveitis 30.8 TNFRSF1B TNF IL6 IL2 CTLA4

Graphical network of the top 20 diseases related to Exanthem:



Diseases related to Exanthem

Symptoms & Phenotypes for Exanthem

MGI Mouse Phenotypes related to Exanthem:

45 (show all 13)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.34 ALB CCR6 CD40LG CRP CTLA4 EGFR
2 homeostasis/metabolism MP:0005376 10.31 ALB CCR6 CD274 CD4 CD40LG CRP
3 cellular MP:0005384 10.29 ALB CD274 CD4 CD40LG CD8A EGFR
4 endocrine/exocrine gland MP:0005379 10.26 ALB CD4 CD40LG CD8A CTLA4 EGFR
5 immune system MP:0005387 10.25 ALB CCR6 CD274 CD4 CD40LG CD8A
6 hematopoietic system MP:0005397 10.23 CCR6 CD274 CD4 CD40LG CD8A CTLA4
7 digestive/alimentary MP:0005381 10.19 ALB CD4 CTLA4 EGFR ERBB2 HRAS
8 mortality/aging MP:0010768 10.17 ALB CD274 CD4 CD40LG CD8A CTLA4
9 integument MP:0010771 10.15 CD274 CD4 CD40LG CD8A CTLA4 EGFR
10 neoplasm MP:0002006 9.86 ALB EGFR ERBB2 HRAS IL2 IL6
11 normal MP:0002873 9.81 ALB CCR6 CD4 CD8A CTLA4 EGFR
12 respiratory system MP:0005388 9.56 CTLA4 EGFR ERBB2 HRAS IL2 IL6
13 skeleton MP:0005390 9.36 CD274 CD40LG CTLA4 EGFR ERBB2 GPT

Drugs & Therapeutics for Exanthem

Drugs for Exanthem (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 683)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vancomycin Approved Phase 4 1404-90-6 14969 441141
2
Enalapril Approved, Vet_approved Phase 4 75847-73-3 40466924 5362032
3
Enalaprilat Approved Phase 4 76420-72-9 6917719
4
Nalbuphine Approved Phase 4 20594-83-6 5311304 5360630
5
Ceftaroline fosamil Approved, Investigational Phase 4 229016-73-3
6
Cefazolin Approved Phase 4 25953-19-9 656510 33255
7
Nevirapine Approved Phase 4 129618-40-2 4463
8
Efavirenz Approved, Investigational Phase 4 154598-52-4 64139
9
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
10
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
11
Clavulanate Approved, Vet_approved Phase 4 58001-44-8 5280980
12
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
13
Sulfadiazine Approved, Investigational, Vet_approved Phase 4 68-35-9 5215
14
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
15
Cefpirome Approved Phase 4 84957-29-9 5479539
16
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
17
Amifostine Approved, Investigational Phase 4 20537-88-6 2141
18
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
19
Menthol Approved Phase 4 2216-51-5 16666
20
Bezafibrate Approved, Investigational Phase 4 41859-67-0 39042
21
Testosterone Approved, Experimental, Investigational Phase 4 58-22-0, 481-30-1 10204 6013
22
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
23
Morphine Approved, Investigational Phase 4 57-27-2 5288826
24
Mannitol Approved, Investigational Phase 4 69-65-8 6251 453
25
Stavudine Approved, Investigational Phase 4 3056-17-5 18283
26
Ledipasvir Approved Phase 4 1256388-51-8 67505836
27
Sofosbuvir Approved Phase 4 1190307-88-0 45375808
28
Cocaine Approved, Illicit Phase 4 50-36-2 446220 5760
29
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
30
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
31
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
32
Ivermectin Approved, Investigational, Vet_approved Phase 4 70288-86-7 6474909
33
Azithromycin Approved Phase 4 83905-01-5 447043 55185
34
Sulfamethoxazole Approved Phase 4 723-46-6 5329
35
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
36
Topiramate Approved Phase 4 97240-79-4 5284627
37
Rifampicin Approved Phase 4 13292-46-1 5381226 5458213
38
Phenytoin Approved, Vet_approved Phase 4 57-41-0 1775
39
Amantadine Approved Phase 4 768-94-5 2130
40
Nicotine Approved Phase 4 54-11-5 942 89594
41
Bupropion Approved Phase 4 34911-55-2, 34841-39-9 444
42
Maraviroc Approved, Investigational Phase 4 376348-65-1 3002977
43
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
44
Clarithromycin Approved Phase 4 81103-11-9 84029
45
Dexlansoprazole Approved, Investigational Phase 4 103577-45-3, 138530-94-6 9578005
46
Praziquantel Approved, Investigational, Vet_approved Phase 4 55268-74-1 4891
47
Cilostazol Approved, Investigational Phase 4 73963-72-1 2754
48
Clopidogrel Approved Phase 4 113665-84-2, 120202-66-6 60606
49
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
50
Fenofibrate Approved Phase 4 49562-28-9 3339

Interventional clinical trials:

(show top 50) (show all 789)
# Name Status NCT ID Phase Drugs
1 Non-randomized Phase-IV-study to Investigate the Efficacy of FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema Unknown status NCT01315990 Phase 4 FOLFIRI + Cetuximab
2 Evaluation of Effectiveness and Safety of Oral Vancomycin in Treatment of Primary Sclerosing Cholangitis. Unknown status NCT02605213 Phase 4 Vancomycin;Placebo
3 Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® Unknown status NCT01553032 Phase 4 Erbitux®
4 Evaluation Whether Higher Retention Rate is in Those of Combined Methadone With N-Acetyl-Cysteine Compared to Those With Methadone Alone During a Six-month Study Unknown status NCT01047956 Phase 4 Methadone; NAC;Methadone
5 A Clinical Study on Anti-Hypertensive Agent (ACEi) and Heart Function Improvement Unknown status NCT01069042 Phase 4 Enalapril
6 An Open-Label Pilot Study to Compare the Efficacy of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids Unknown status NCT01583478 Phase 4
7 Comparison of Efficacy and Safety of the Postoperative Analgesia Methods for Supratentorial Craniotomy by Integrated Pulmonary Index (IPI) Unknown status NCT02929147 Phase 4 Morphine;Dexketoprofen;Placebo
8 Comparison of Analgesic Efficacy of Two Different Doses of Dexmedetomidine as Adjuncts to Lidocaine for Intravenous Regional Anesthesia: Randomized Clinical Trial. Unknown status NCT03399474 Phase 4 Dexmedetomidine Injection 0.25 ug/kg;Lidocaine;Nalbuphine;Paracetamol;Diclofenac sodium (Voltaren®);Dexmedetomidine Injection 0.5ug/kg
9 ASSESSMENT OF GH-IGF1 AXIS AND TO STUDY RESPONSE TO GH THERAPY IN CHILDREN WITH CML IN REMISSION HAVING GH DEFICIENCY Unknown status NCT01901666 Phase 4 Growth Hormone
10 IDC 56: A Randomized Double-blinded Study Comparing Ceftaroline to Standard of Care Therapy With Cefazolin and Vancomycin as Surgical Prophylaxis for High Risk Orthopedic and Cardiac Surgeries Unknown status NCT02307006 Phase 4 Ceftaroline;Cefazolin / Vancomycin
11 Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration Completed NCT00280514 Phase 4 cefpirome and moxifloxacin administration
12 A Parallel, Evaluator-Blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Two Marketed Topical Skin Protectants Containing Zinc Oxide in Children With Diaper Rash Completed NCT00219466 Phase 4
13 A Multicenter, Randomized, Open-label, Controlled Study of Nevirapine (VIRAMUNE®) and a Short Course of Prednisone to Determine the Safety and Effectiveness of This Strategy in Preventing Nevirapine (VIRAMUNE®) Associated Rash. Completed NCT02184299 Phase 4 Nevirapine;Prednisone
14 A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster Completed NCT02152800 Phase 4 valacyclovir hydrocholoride
15 Open-Label Prospective Trial Evaluating the Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities Completed NCT00158041 Phase 4 Amifostine administered subcutaneously
16 Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™ Completed NCT02958345 Phase 4
17 Prospective 2-Year Longitudinal Study to Assess for Miconazole Resistance in Candida Spp. With Repeated Treatment Courses of 0.25% Miconazole Nitrate Ointment in Neonates and Infants up to 1 Year of Age With Recurrent Moderate-Severe Diaper Dermatitis Complicated by Cutaneous Candidiasis Completed NCT00702507 Phase 4 0.25 % Miconazole Nitrate Ointment
18 Randomized Controlled Trial Comparing the Efficacy and Safety of Calmoseptine Ointment and Desitin Maximum Strength 40% Zinc Oxide Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants Completed NCT02716415 Phase 4 Calmoseptine Ointment;Destin Maximum Strength 40% Zinc
19 Early Effect Of Bezafibrate On Fibrinogen Levels, Inflammatory Response And Clinical Impact, In Patients With ST Elevation Acute Myocardial Infarction Completed NCT02291796 Phase 4 Bezafibrate
20 Physiologic Testosterone Replacement in Women With Hypopituitarism Completed NCT00144391 Phase 4 Transdermal Testosterone gel
21 Analgetic Effectiveness of Acupuncture When Compared to a Standardised Analgesic Regimen in the Treatment of Herpes Zoster Neuralgia Completed NCT00885586 Phase 4 gabapentine
22 Aloe Vera and Chlorhexidine as Preventive Oral Antiseptics Against the Appearance of Traumatic Oral Ulcers in Patients With Fixed Orthodontics: a Randomized Clinical Trial Completed NCT03633292 Phase 4 Antiseptic clorhexidine gel (Lacer, Barcelona, Spain);Master formula of aloe vera gel 80%
23 A Multi-center, Double-blinded Randomized Trial for Genotype Based Personalized Prescription of Nevirapine Completed NCT00986063 Phase 4
24 Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome Completed NCT02961998 Phase 4 Celecoxib;Sorafenib
25 Pyrimethamine Plus Sulfadiazine Versus Trimethoprim Plus Sulfamethoxazole for Treatment of Toxoplasmic Encephalitis in AIDS Patients: A Randomized Controlled Trial. Completed NCT00367081 Phase 4 TMX-SMX (Bactrim(R));Pyrimethamine plus Sulfadiazine plus leucoverin
26 The Qure Study: Q-fever Fatigue Syndrome - Response to Treatment Completed NCT01318356 Phase 4 Doxycycline;Placebo
27 A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Effacy and Safety of Topiramate in Subjects With Restless Legs Syndrome (RLS) Completed NCT00200941 Phase 4 Topiramate
28 A Comparative Evaluation of Diclofenac Sodium Transdermal Patch, Oral Diclofenac Sodium With Intramuscular Injections of Diclofenac Sodium in Patients Suffering From Oral Pain: A Randomized Control Trial Completed NCT03221946 Phase 4 Diclofenac Sodium;Diclofenac sodium;Diclofenac
29 A Retrospective Study to Compare the 3-Year Antiviral Efficacy of Nevirapine and Efavirenz in Combination With D4t and 3tc in 2NN Patients and of Trizivir Versus Trizivir Plus Nevirapine in CHARM Patients Completed NCT00127972 Phase 4 stavudine;lamivudine;nevirapine;efavirenz;trizivir
30 Comparison of Nevirapine Levels With and Without Dose Escalation in HIV-infected Patients Commencing Antiretroviral Therapy Who Are Also Receiving Rifampicin Based Anti-tuberculous Therapy Completed NCT00617643 Phase 4 Nevirapine without dose escalation;Nevirapine initiation with dose escalation
31 A Prospective, Randomized, Placebo-controlled Trial of Pre-transplant and Prompt Post-transplant Treatment With Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation Completed NCT01915082 Phase 4 Azithromycin;Ora-Plus
32 Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases Completed NCT02040116 Phase 4 Rituximab Infusion
33 The Effect of Amantadine on Movement Disorder in Ataxia-Telangiectasia Completed NCT00950196 Phase 4 amantadine sulphate
34 Proteomic Profiling for Influenza Vaccination Completed NCT00133588 Phase 4
35 A Randomized, Double-blind, Placebo-controlled, Trial of Lamotrigine add-on Therapy in Outpatients With Bipolar Disorder, Depressed or Mixed Phase and Cocaine Dependence Completed NCT00280293 Phase 4 Lamotrigine;Placebo
36 The Immunologic Effects of HCV Therapy With Fixed Dose Combination Ledipasvir/Sofosbuvir (HARVONI) in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs. Completed NCT02347345 Phase 4 Harvoni (Fixed dose combination ledipasvir/sofosbuvir)
37 A Comparison of Bupropion SR and Placebo for Smoking Cessation Completed NCT00176449 Phase 4 Bupropion SR;Placebo Oral Tablet
38 A Double Blinded Randomized Controlled Trial to Compare the Efficacy, Time to Onset, and Duration of Two Botulinum Type A Exotoxins (Onabotulinum Toxin A and Abobotulinum Toxin A) in the Treatment of "Crow's Feet." Completed NCT01529788 Phase 4 Right lateral orbital injection of Botox Cosmetic or Dysport;Left lateral orbital injection of Botox Cosmetic or Dysport
39 Effective and Safe Morphine Dose for Patient Controlled Anesthesia in Supratentorial Craniotomies Completed NCT04313374 Phase 4 Morphine PCA 1 mg;Morphine PCA 0,5 mg;Placebo
40 Comparative Study of the Levofloxacin-Based and Clarithromycin-Based Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication and Change of Gut Flora and Drug Susceptibility Before and After Treatment Completed NCT00816140 Phase 4 Cravit based triple therapy;Klaricid based triple therapy
41 Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Highly Endemic Areas of Northeastern Brazil Completed NCT00403611 Phase 4 Praziquantel 60 mg/kg;Praziquantel 40 mg/kg
42 A Trial of Evaluating Additional Benefit of Cilostazol to Dual Antiplatelet Therapy in Patients With Long or Multi-vessel Coronary Artery Disease Underwent Biolimus-Eluting Stent Implantation Completed NCT01192724 Phase 4 Cilostazol;Aspirin;Clopidogrel
43 A Pilot Evaluation of the Pharmacokinetics, Efficacy and Safety of Switching From Efavirenz to Maraviroc Administered at 600mg Then 300mg Twice-daily in Patients Suppressed on an Efavirenz-containing Regimen as Initial Therapy Completed NCT01190293 Phase 4 Maraviroc
44 A Prospective, Randomized, Double Blind Study Comparing the Efficacy and Safety of Fentanyl Nasal Spray to Placebo as an Analgesic, in Patients Undergoing Outpatient Cystoscopic Procedures Completed NCT01708122 Phase 4 Fentanyl;saline
45 Efficacy and Safety of Extended Release Niacin-Fenofibrate Combination and Monotherapy for the Treatment of Atherogenic Dyslipidemia in Obese Females Completed NCT03615534 Phase 4 Fenofibrate
46 Evaluation of Ureteral Patency in the Post-indigo Carmine Era Completed NCT02677623 Phase 4 Pyridium;Sodium Fluorescein;Mannitol
47 Phenytoin as an Augmentation for SSRI Failures: A Controlled Study Completed NCT00146237 Phase 4 phenytoin
48 Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication Completed NCT03650543 Phase 4 amoxicillin clarithromycin omeprazole 1;amoxicillin clarithromycin omeprazole 2
49 Pneumonia in Children: Aetiology, Ideal Antibiotic Duration, Quality of Life Completed NCT02258763 Phase 4 Amoxicillin-Potassium Clavulanate Combination;Placebo
50 A Study of Sertraline to Prevent PTSD Completed NCT00182078 Phase 4 Placebo;Sertraline

Search NIH Clinical Center for Exanthem

Cochrane evidence based reviews: exanthema

Genetic Tests for Exanthem

Anatomical Context for Exanthem

MalaCards organs/tissues related to Exanthem:

40
Skin, Lung, Breast, Testes, Liver, T Cells, Bone

Publications for Exanthem

Articles related to Exanthem:

(show top 50) (show all 26484)
# Title Authors PMID Year
1
Maternal oral contraceptive pill use and the risk of atopic diseases in the offspring: A systematic review and meta-analysis. 42
32311929 2020
2
A randomized controlled clinical study of acupuncture therapy for Seborrheic alopecia in young and middle ages: Study protocol clinical trial (SPIRIT compliant). 42
32332635 2020
3
TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis. 42
32436460 2020
4
A review on Zika virus outbreak, epidemiology, transmission and infection dynamics. 61
32158705 2020
5
Optical coherence tomography angiography findings in macular toxoplasma retinochoroiditis: A case report. 61
32551402 2020
6
Treatment of status epilepticus with zonisamide: A multicenter cohort study of 34 patients and review of literature. 61
32417381 2020
7
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus. 61
31761943 2020
8
School Nurses on the Front Lines of Healthcare: Infectious Diseases Popularized in the News. 61
32491976 2020
9
Histologic comparison of tumor necrosis factor-α inhibitor-induced psoriasis and psoriasis vulgaris. 61
31931086 2020
10
Epidemiology of herpes simplex and varicella zoster virus in cerebrospinal fluid of patients suffering from meningitis in Iran. 61
32528686 2020
11
Clinical and epidemiological comparison of Rickettsia parkeri rickettsiosis, related to Amblyomma triste and Amblyomma tigrinum, in Argentina. 61
32386908 2020
12
A Case of Prolonged Angioedema After Cardiac Surgery. 61
31948888 2020
13
Breastfeeding initiation or duration and longitudinal patterns of infections up to 2 years and skin rash and respiratory symptoms up to 8 years in the EDEN mother-child cohort. 61
31970921 2020
14
Three Patterns of Cutaneous Involvement in Granulomatosis with Polyangiitis. 61
32455005 2020
15
Is the ADP ribose site of the Chikungunya virus NSP3 Macro domain a target for antiviral approaches? 61
32333884 2020
16
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer. 61
31714586 2020
17
Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome/toxic epidermal necrolysis. 61
32200005 2020
18
Prurigo pigmentosa induced by ketosis ("keto rash"): a demonstrative case and internet search results. 61
32297975 2020
19
Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients. 61
32305439 2020
20
Reply to "Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients": Discussing specificity. 61
32380215 2020
21
Association Between Early Immune-related Adverse Events and Clinical Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors. 61
32113737 2020
22
Dermatology in primary care: an audit of the proportion of patients who present to general practice with a dermatological problem that could be self-managed. 61
32554636 2020
23
A Randomized, Blinded, Prospective Clinical Study Comparing Small-Particle Versus Cohesive Polydensified Matrix Hyaluronic Acid Fillers for the Treatment of Perioral Rhytids. 61
32506124 2020
24
Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations. 61
32497289 2020
25
Central nervous system infections produced by varicella zoster virus. 61
32332223 2020
26
Hemophagocytic syndrome as a complication of acute pancreatitis: A case report. 61
32548169 2020
27
Hemophagocytic lymphohistiocytosis is associated with Bartonella henselae infection in a patient with multiple susceptibility genes. 61
32517705 2020
28
New aspect of allergic contact dermatitis, an inflammatory skin disorder mediated by mast cells: Can IL-38 help? 61
32259663 2020
29
Management of Fever in Infants and Young Children. 61
32538597 2020
30
A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study. 61
32009149 2020
31
Insight into the Time Course of Type III Kounis Syndrome: A Case Report. 61
32536494 2020
32
Zika virus in Brazil and worldwide: a narrative review. 61
32576082 2020
33
A descriptive analysis of an outbreak of measles and a multilevel mixed-effects analysis of factors associated with case isolation in healthcare settings, London (February-June 2016). 61
32434087 2020
34
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. 61
32299776 2020
35
Analysis of risk factors contributing to road traffic accidents in a tertiary care hospital. A hospital based cross-sectional study. 61
32381399 2020
36
DRESS syndrome in response to Denosumab: First documented case report. 61
31890758 2020
37
Tolerability of hair cleansing conditioners: a double-blind randomized, controlled trial designed to evaluate consumer complaints to the U.S. Food and Drug Administration. 61
32122177 2020
38
Frequency and severity of hypersensitivity reactions in patients after VenaSeal™ cyanoacrylate treatment of superficial venous insufficiency. 61
31554473 2020
39
A nurse-led, rheumatologist-assisted telemedicine intervention for dose escalation of urate-lowering therapy in gout. 61
32483906 2020
40
Cetuximab Maintenance Therapy in Patients with Unresectable Wild-Type RAS and BRAF Metastatic Colorectal Cancer: A Single-Institute Prospective Study. 61
32378072 2020
41
Implementation and Impact of a Store-and-Forward Teledermatology Platform in an Urban Academic Safety-Net Health Care System. 61
32522105 2020
42
Discovery of new serum biomarker panels for systemic lupus erythematosus diagnosis. 61
31899518 2020
43
Association of omentin-1, adiponectin, and resistin genetic polymorphisms with systemic lupus erythematosus in a Chinese population. 61
32179245 2020
44
Prevalence and influential factors of thrombocytopaenia in systemic lupus erythematosus patients: a retrospective analysis of 3140 cases in a Chinese population. 61
32356674 2020
45
Acute orbital myositis preceding vesicular rash eruption in herpes zoster ophthalmicus. 61
31879064 2020
46
Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases. 61
32487712 2020
47
Arboviruses and Muscle Disorders: From Disease to Cell Biology. 61
32516914 2020
48
Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease. 61
32565346 2020
49
Safety and clinical effectiveness of Withania Somnifera (Linn.) Dunal root in human ailments. 61
32201301 2020
50
Physician preferences for non-metastatic castration-resistant prostate cancer treatment. 61
32571276 2020

Variations for Exanthem

Expression for Exanthem

Search GEO for disease gene expression data for Exanthem.

Pathways for Exanthem

Pathways related to Exanthem according to GeneCards Suite gene sharing:

(show top 50) (show all 60)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.85 TNFRSF1B TNF IL6 IL2 HRAS ERBB2
2
Show member pathways
13.65 TNFRSF1B TNF IL6 IL2 IL1RN HRAS
3
Show member pathways
13.65 TNFRSF1B TNF IL6 IL2 IL1RN ICOSLG
4
Show member pathways
13.46 ICOSLG HRAS ERBB2 EGFR CTLA4 CD8A
5
Show member pathways
13.37 TNFRSF1B TNF IL6 IL2 HRAS ERBB2
6
Show member pathways
13.3 TNFRSF1B TNF IL6 IL2 IL1RN HRAS
7
Show member pathways
13.17 TNFRSF1B TNF IL6 IL2 HRAS ERBB2
8
Show member pathways
13.01 TNF IL6 IL2 HRAS ERBB2 EGFR
9
Show member pathways
12.96 TNFRSF1B TNF IL6 HRAS EGFR CD4
10
Show member pathways
12.8 TNFRSF1B TNF IL6 IL2 HRAS
11
Show member pathways
12.74 TNF IL6 IL1RN HRAS EGFR
12
Show member pathways
12.7 TNFRSF1B TNF IL6 IL2 EGFR CD40LG
13
Show member pathways
12.67 TNF IL6 IL2 ICOSLG CTLA4 CD8A
14
Show member pathways
12.66 TNFRSF1B TNF HRAS EGFR CD40LG CD4
15
Show member pathways
12.61 TNFRSF1B TNF IL2 ICOSLG HRAS CD40LG
16
Show member pathways
12.53 TNFRSF1B TNF HRAS ERBB2 EGFR
17
Show member pathways
12.53 TNF IL6 IL2 HRAS ERBB2 EGFR
18
Show member pathways
12.42 IL6 IL2 HRAS ERBB2 EGFR
19
Show member pathways